Prostate Cancer - Results from #26920

Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer - Abstract October 17, 2011

Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer - Abstract October 17, 2011

Comorbidities, treatment and ensuing survival in men with prostate cancer - Abstract October 17, 2011

A chemically induced vaccine strategy for prostate cancer - Abstract October 17, 2011

Dimethyl sulfoxide-sodium bicarbonate infusion for palliative care and pain relief in patients with metastatic prostate cancer - Abstract October 17, 2011

Immunotherapy of prostate cancer: Identification of new treatments and targets for therapy, and role of WAP domain-containing proteins - Abstract October 17, 2011

Matched-pair analysis and dosimetric variations of two types of software for interstitial permanent brachytherapy for prostate cancer - Abstract October 17, 2011

Two-step transurethral surgery of the prostate and permanent implant brachytherapy for patients with lower urinary tract symptoms and low- to intermediate-risk prostate cancer - Abstract October 17, 2011

Urethra low-dose tunnels: Validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy - Abstract October 17, 2011

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy - Abstract October 14, 2011

New drugs for prostate cancer - Abstract October 14, 2011

Compliance with biopsy recommendations of a prostate cancer risk calculator - Abstract October 14, 2011

Optimization of PSA screening policies: A comparison of the patient and societal perspectives - Abstract October 14, 2011

Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: Can the change in prostate-specific antigen reliably guide prostate biopsy decisions? - Abstract October 14, 2011

Complete clinical and biological response to zoledronic acid in castrate-resistant prostate cancer metastatic to bone - Abstract October 14, 2011

Complications after radical prostatectomy: Anastomotic stricture and rectourethral fistula - Abstract October 14, 2011

MRI navigated stereotactic prostate biopsy : Fusion of MRI and real-time transrectal ultrasound images for perineal prostate biopsies - Abstract October 14, 2011

Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate specific antigen-era: Incidence and survival - Abstract October 13, 2011

Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer - Abstract October 13, 2011

Prostate cancer: Multiparametric MR imaging for detection, localization, and staging - Abstract October 13, 2011

Page 1347 of 1434